Structure

InChI Key JGPXDNKSIXAZEQ-SBBZOCNPSA-N
Smile O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F
InChI
InChI=1S/C20H19F2N5O2/c21-11-5-12-13(7-24-17(12)23-6-11)18-25-8-14(22)19(27-18)26-16-10-3-1-9(2-4-10)15(16)20(28)29/h5-10,15-16H,1-4H2,(H,23,24)(H,28,29)(H,25,26,27)/t9?,10?,15-,16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H19F2N5O2
Molecular Weight 399.4
AlogP 3.6
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 4.0
Polar Surface Area 103.79
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Polymerase basic protein 2 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Influenza, Human 2 D007251 ClinicalTrials
Liver Diseases 1 D008107 ClinicalTrials
Renal Insufficiency, Chronic 1 D051436 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL3318007
DrugBank DB14974
FDA SRS DFC121MXC3
SureChEMBL SCHEMBL2128140
ZINC ZINC000098208077